Cargando…
Comment on Ramai et al. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers 2022, 14, 2947
Autores principales: | Lissing, Mattias, Vassiliou, Daphne, Harper, Pauline, Sardh, Eliane, Wahlin, Staffan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913564/ https://www.ncbi.nlm.nih.gov/pubmed/36765753 http://dx.doi.org/10.3390/cancers15030795 |
Ejemplares similares
-
Reply to Lissing et al. Comment on “Ramai et al. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers 2022, 14, 2947”
por: Ramai, Daryl, et al.
Publicado: (2023) -
Risk of primary liver cancer in acute hepatic porphyria patients: A matched cohort study of 1244 individuals
por: Lissing, Mattias, et al.
Publicado: (2022) -
Challenges in the management of acute intermittent porphyria with recurrent attacks during pregnancy: A case report
por: Vassiliou, Daphne, et al.
Publicado: (2020) -
Comment on Kesić et al. Early Diagnostics of Vulvar Intraepithelial Neoplasia. Cancers 2022, 14, 1822
por: De Giorgi, Vincenzo, et al.
Publicado: (2022) -
Comment on Muzzioli et al. Are Front-of-Pack Labels a Health Policy Tool? Nutrients 2022, 14, 771
por: Aguenaou, Hassan, et al.
Publicado: (2022)